Axitinib and Bavencio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Axitinib (axitinib) and Bavencio (avelumab). Common drug interactions include hypertension among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Axitinib and Bavencio. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Axitinib?

Axitinib has active ingredients of axitinib. eHealthMe is studying from 3,179 Axitinib users. Check the latest studies of Axitinib.

What is Bavencio?

Bavencio has active ingredients of avelumab. eHealthMe is studying from 1,606 Bavencio users. Check the latest studies of Bavencio.

On Jul, 29, 2026

66 people who take Axitinib and Bavencio together, and have interactions are studied.

Axitinib and Bavencio drug interactions.

What are the common drug interactions of Axitinib and Bavencio, by gender? *:

female:

Hypertension (high blood pressure)
Neuropathy peripheral (surface nerve damage)
Scleroderma (hard skin)
Pleural effusion (water on the lungs)
Blood pressure increased
Chest pain
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Disease progression

male:

Death
Disease progression
Retinal vein occlusion (a blockage of the small veins that carry blood away from the retina)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Autoimmune pancreatitis (autoimmune pancreatitis (aip) is an increasingly recognized type of chronic pancreatitis)
Blood creatinine increased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Dysphonia (speech disorder attributable to a disorder of phonation)
Hypertension (high blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the common drug interactions of Axitinib and Bavencio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Adrenal disorder
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Hepatitis (inflammation of the liver)
Pulmonary sarcoidosis (growth of tiny collections of inflammatory cells in lungs)

50-59:

Colitis (inflammation of colon)
Diarrhoea
Disease progression
Fatigue (feeling of tiredness)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Hypertension (high blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Metastases to spine (cancer spreads to spine)
Retinal vein occlusion (a blockage of the small veins that carry blood away from the retina)
Transaminases increased

60+:

Hypertension (high blood pressure)
Neuropathy peripheral (surface nerve damage)
Pyrexia (fever)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Autoimmune pancreatitis (autoimmune pancreatitis (aip) is an increasingly recognized type of chronic pancreatitis)
Blood creatinine increased
Cardiac failure
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Haemorrhage (bleeding)

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 35 people, 53.03%
Renal Cell Carcinoma (a kidney cancer): 10 people, 15.15%

* Approximation only. Some reports may have incomplete information.

Do you take Axitinib and Bavencio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously